The European Project ZAPI (Zoonoses Anticipation and Prepardness Initiative) held its annual Meeting in Utrecht, the Netherlands, on March 26-27, 2017. ZAPI is the first “One Health” project of IMI (Innovative Medicines Initiative) which connects experts on animal and public Health.The main objective of the ZAPI project is to enable swift response to major new infectious disease threats in Europe and throughout the world by designing new manufacturing processes for delivering effective control tools against (re-)emerging zoonotic diseases. ZAPI is a collaborative partnership between more than 20 European partners, including leading human and veterinary research institutions, non-governmental organizations, regulatory agencies, expert academic groups, and vaccine and biotech manufacturers. One of the partners of this consortium is CReSA (Centre de Recerca en Sanitat Animal), a center from IRTA (Institut de Recerca i Tecnologia Agroalimentàries), and Dr. Joaquim Segalés, Dr. Albert Bensaid and Dr. Júlia Vergara-Alert, three researcher of the project, attended the Meeting.During the meeting, Dr. Vergara-Alert presented the latest developments of the group concerning animal models for the study of MERS-CoV virus (Middle East respiratory syndrome coronavirus), and ex vivo models and other techniques that are being developed at CReSA.
